These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12431660)

  • 1. Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin.
    André-Schmutz I; Le Deist F; Hacein-Bey S; Hamel Y; Vitetta E; Schindler J; Fischer A; Cavazzana-Calvo M
    Transplant Proc; 2002 Nov; 34(7):2927-8. PubMed ID: 12431660
    [No Abstract]   [Full Text] [Related]  

  • 2. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity.
    Montagna D; Yvon E; Calcaterra V; Comoli P; Locatelli F; Maccario R; Fisher A; Cavazzana-Calvo M
    Blood; 1999 May; 93(10):3550-7. PubMed ID: 10233908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin.
    Michálek J; Collins RH; Vitetta ES
    Neoplasma; 2003; 50(4):296-9. PubMed ID: 12937844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro.
    Vaclavkova P; Cao Y; Wu LK; Michalek J; Vitetta ES
    Bone Marrow Transplant; 2006 Mar; 37(6):559-67. PubMed ID: 16444279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
    Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
    Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific anti-interleukin-2 receptor Bk chain immunotoxin.
    Valteau-Couanet D; Cavazzana-Calvo M; Le Deist F; Fromont C; Fischer A
    Transplantation; 1993 Dec; 56(6):1574-6. PubMed ID: 8279044
    [No Abstract]   [Full Text] [Related]  

  • 8. Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.
    Hartwig UF; Nonn M; Khan S; Meyer RG; Huber C; Herr W
    Bone Marrow Transplant; 2006 Feb; 37(3):297-305. PubMed ID: 16327814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
    André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
    Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin.
    Cavazzana-Calvo M; Fromont C; Le Deist F; Lusardi M; Coulombel L; Derocq JM; Gerota I; Griscelli C; Fischer A
    Transplantation; 1990 Jul; 50(1):1-7. PubMed ID: 2142343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial.
    Maschan M; Blagov S; Shelikhova L; Shekhovtsova Z; Balashov D; Starichkova J; Kurnikova E; Boyakova E; Muzalevskii Y; Kazachenok A; Trakhtman P; Osipova E; Khripkova N; Zhogov V; Novichkova G; Maschan A
    Bone Marrow Transplant; 2018 Mar; 53(3):264-273. PubMed ID: 29269793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
    Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
    Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.
    Filipovich AH; Vallera D; McGlave P; Polich D; Gajl-Peczalska K; Haake R; Lasky L; Blazar B; Ramsay NK; Kersey J
    Transplantation; 1990 Sep; 50(3):410-5. PubMed ID: 1698319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
    Martin PJ; Pei J; Gooley T; Anasetti C; Appelbaum FR; Deeg J; Hansen JA; Nash RA; Petersdorf EW; Storb R; Ghetie V; Schindler J; Vitetta ES
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):552-60. PubMed ID: 15282533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation.
    Bishop MR; Steinberg SM; Gress RE; Hardy NM; Marchigiani D; Kasten-Sportes C; Dean R; Pavletic SZ; Gea-Banacloche J; Castro K; Hakim F; Krumlauf M; Read EJ; Carter C; Leitman SF; Fowler DH
    Br J Haematol; 2004 Sep; 126(6):837-43. PubMed ID: 15352988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of graft-versus-host reactivity after small bowel transplantation: ex vivo treatment of intestinal allografts with an anti-T cell immunotoxin.
    Clark CL; Smith GJ; Crane PW; Price BA; Lear PA; Fabre JW; Wood RF
    Clin Exp Immunol; 1992 May; 88(2):220-5. PubMed ID: 1373997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin.
    Lee SC; Seo KW; Kim HJ; Kang SW; Choi HJ; Kim A; Kwon BS; Cho HR; Kwon B
    Cell Transplant; 2015; 24(6):1167-81. PubMed ID: 24594433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of ricin-immunotoxin mediated T cell depletion to allogeneic hematopoietic stem cell transplantation].
    Lai YY; Guo NL; Huang XJ; Xu LP; Chen H; Wang SQ; Zheng HY; Li Y; Shen BF; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):270-3. PubMed ID: 15228648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of activated alloreactive T cells in prevention of acute graft-versus-host disease.
    Hu HZ; New JY; Li B; Chan SH; Yap EH
    Transplant Proc; 2000 Nov; 32(7):2456-7. PubMed ID: 11120242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.